Evaluasi Penerapan Terapi MDT pada Kasus Kusta di Kota Lhokseumawe
DOI:
https://doi.org/10.55606/jurrikes.v4i1.4542Keywords:
Characteristics, Leprosy, MDT, Treatment OverviewAbstract
Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae. It is a neglected tropical disease, still found in more than 120 countries, with more than 200,000 new cases reported each year.. The purpose of this research is to characterize leprosy patients in Lhokseumawe City and to describe the Multi Drug Therapy therapy. Information about the therapy, including the kind of leprosy, age, gender, employment, and the precise period of treatment, is evaluated in this research. Instruments for measurement were derived using data collected from medical records in this cross-sectional observational investigation. A whole sampling population was used in the sampling procedure, with 42 respondents making up the sample. Based on these findings, MB leprosy is the most frequent form of the disease (90.5% of cases), men make up the majority (64.3%) of leprosy patients, and the majority of leprosy patients are adults (88.1%). Results from the MDT treatment protocol indicated that 76.2% of patients were considered to have finished therapy (RFT), with the biggest occupational category being patients who did not work, accounting for 50% of the total. It is imperative that leprosy officers work to promote health promotion in order to raise awareness, decrease negative stigma, and speed up the discovery of leprosy cases
Downloads
References
Andriani, E., Khotimah, H., & Supriyadi, B. (2019). Dukungan keluarga dalam kepatuhan pengobatan pada penderita kusta. Community of Publishing in Nursing (COPING), 75–80.
Assis, B. P. N., Lyon, S., Grossi, M. A. F., & Rocha, M. O. C. (2019). Risk factors for physical disability upon release from multidrug therapy in new cases of leprosy at a referral center in Brazil. Revista do Instituto de Medicina Tropical de São Paulo, 61, e13. https://doi.org/10.1590/S1678-9946201961013
Bhat, R. M., & Prakash, C. (2012). Leprosy: An overview of pathophysiology. Interdisciplinary Perspectives on Infectious Diseases, 2012, Article 181089. https://doi.org/10.1155/2012/181089
De Almeida-Neto, F. B., Assis Costa, V. M., Oliveira-Filho, A. F., De Souza Franco, E., Tavares Julião De Lima, E. V., Barros De Lorena, V. M., Oliveira De Souza, V. M., & De Sousa Maia, M. B. (2014). TH17 cells, interleukin-17 and interferon-γ in patients and household contacts of leprosy with multibacillary and paucibacillary forms before and after the start of chemotherapy treatment. Journal of the European Academy of Dermatology and Venereology, 29(7), 1354–1361. https://doi.org/10.1111/jdv.12869
Jariyakulwong, N., Julanon, N., & Saengboonmee, C. (2022). Lepromatous leprosy with a suspected 30-year incubation period: A case report of a practically eradicated area. Journal of Taibah University Medical Sciences, 17(4), 602–605. https://doi.org/10.1016/j.jtumed.2021.12.005
Jayanti, K. D. (2014). Perbedaan faktor risiko penyakit kusta tipe PB dan MB pada anak di Kabupaten Jember tahun 2010. Jurnal Kesehatan Lingkungan, 9(1), 76–99.
Jurusan Ilmu Kesehatan Masyarakat, Fakultas Ilmu Keolahragaan, Universitas Negeri Semarang. (2020). Analisis faktor risiko yang berhubungan dengan kejadian kusta di Kabupaten Brebes.
Kementerian Kesehatan Republik Indonesia. (2018). InfoDatin Kusta. Jakarta: Kemenkes RI.
Kementerian Kesehatan Republik Indonesia. (2018). Peraturan Menteri Kesehatan Republik Indonesia Nomor 4 Tahun 2018 tentang Penanggulangan Kusta. Berita Negara Republik Indonesia, 151(2), 10–17.
Kementerian Kesehatan Republik Indonesia. (2020a). Pedoman nasional pelayanan kedokteran tata laksana kusta. Jakarta: Kemenkes RI.
Kementerian Kesehatan Republik Indonesia. (2020b). Tata laksana. Kamus Besar Bahasa Indonesia (KKBI) Daring, 106.
Kementerian Kesehatan Republik Indonesia. (2022). Laporan validasi data kusta tahun 2021. Jakarta: Kemenkes RI.
Kementerian Kesehatan Republik Indonesia. (2023). Laporan kinerja 2022 Direktorat Pencegahan dan Pengendalian Penyakit Menular Kementerian Kesehatan. Jakarta: Kemenkes RI.
Peng, J. Y., Sun, P. W., Wang, L., Wang, H. S., Yu, M. W., & Gu, H. (2022). Epidemiological features of leprosy in China, 2020. International Journal of Dermatology and Venereology, 5(4), 231–235. https://doi.org/10.1097/JD9.0000000000000251
Rahmawati, F., Rakhmawatie, M. D., & Indrastiti, R. (2017). Efektivitas pengobatan kombinasi rifampisin-klaritromisin dengan MDT WHO terhadap derajat kesembuhan pasien lepra tipe PB. Jurnal Ilmu Kedokteran dan Kesehatan.
Siregar, T., & Ratnawati, D. (2019). Perilaku sehat penderita kusta dengan kepatuhan konsumsi MDT di Puskesmas Limo Kota Depok Jawa Barat. CARE: Jurnal Ilmiah Ilmu Kesehatan, 8(3), 127–137.
Soeroso, J., Isbagio, H., Kalim, H., Broto, R., & Pramudyo, R. (2006). Buku ajar ilmu penyakit dalam. Jakarta: Pusat Penerbitan FKUI.
World Health Organization. (2021). Towards zero leprosy: Global leprosy (Hansen’s disease) strategy 2021–2030. Geneva: WHO.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 JURNAL RISET RUMPUN ILMU KESEHATAN

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
_001.jpg)




